platinum has been researched along with Neoplasms, Pleural in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (13.04) | 18.2507 |
2000's | 4 (17.39) | 29.6817 |
2010's | 10 (43.48) | 24.3611 |
2020's | 6 (26.09) | 2.80 |
Authors | Studies |
---|---|
Danese, MD; Daumont, M; Gleeson, M; Lubeck, D; Nwokeji, E; Penrod, JR | 1 |
Duan, J; Jiang, Z; Zeng, X | 1 |
Asghari, AB; Chai, SM; Creaney, J; Dick, IM; Firth, T; Hansen, J; Lee, YCG; Louw, A; Lynggaard, LA; Meristoudis, C; Panou, V; Røe, OD; Szejniuk, WM; van Vliet, C; Vyberg, M | 1 |
Dunne, B; Harden, S; Hoang, W; John, T; Leal, JL; Xue, J | 1 |
Belletti, M; Bono, F; Bonomi, M; Canova, S; Carlucci, L; Ceresoli, GL; Cortinovis, DL; D'Aveni, A; De Angelis, A; De Simone, I; Galli, F; Gelsomino, F; Grosso, F; Mencoboni, M; Pasello, G; Perrino, M; Rulli, E; Zucali, PA | 1 |
Ilonen, I; Järvinen, T; Koli, K; Lauri, H; Lemström, K; Myllärniemi, M; Ollila, H; Paajanen, J; Räsänen, J; Ritvos, O; Rouvinen, E; Sutinen, E | 1 |
Archila, P; Arrieta, O; Bacon, L; Báez, R; Campos Gómez, S; Cardona, AF; Carranza, H; Chirinos, L; Corrales, L; Cuello, M; de Lima, VCC; Freitas, HC; González, L; Granados, ST; Karachaliou, N; Martín, C; Mas, L; Núñez Cerrillo, G; Oblitas, G; Otero, J; Pérez, MA; Ramírez-Tirado, LA; Remolina Bonilla, YA; Rodriguez, J; Rojas, L; Rosell, R; Ruiz-Patiño, A; Trejo-Rosales, R; Vargas, C; Zatarain-Barrón, ZL | 1 |
Alewine, C; Calzone, K; Churpek, JE; Desai, A; Gadiraju, M; Gao, S; Gulsuner, S; Hassan, R; Hesdorffer, M; Khan, J; Kindler, HL; King, MC; Lee, MK; Mian, I; Morrow, B; Padiernos, E; Panou, V; Patel, S; Raffeld, M; Schrump, DS; Steinberg, SM; Thomas, A; Walsh, T; Wei, JS; Xi, L; Zhang, J | 1 |
Barrington, S; Cane, P; Dunn, JT; Lal, R; Landau, D; Lang-Lazdunski, L; McLennan, B; Papa, S; Popat, S; Prevost, AT; Shah, R; Spicer, J; Viney, Z | 1 |
Akca, Z; Aksahin, A; Aslan, T; Berk, V; Buyukcelik, A; Erden, A; Karaca, H; Mutlu, H; Ozkan, M | 1 |
Alessio, M; Bonarrigo, I; Gabano, E; Osella, D; Ravera, M; Zanellato, I | 1 |
Kang, YM; Lin, DJ; Liu, QH; Tian, GY; Wan, YY; Yang, SX; Yao, F; Yao, ZH | 1 |
Dyszkiewicz, W; Kalinka-Warzocha, E; Knetki-Wróblewska, M; Kowalski, DM; Krawczyk, P; Krzakowski, M; Kucharczyk, T; Milanowski, J; Powrózek, T; Ramlau, R; Winiarczyk, K | 1 |
Felley-Bosco, E; Friess, M; Frischknecht, L; Korol, D; Opitz, I; Soltermann, A; Stahel, R; Thies, S; Vrugt, B; Weder, W | 1 |
Ishida, H; Kaneko, K; Kobayashi, K; Nitanda, H; Sakaguchi, H; Yamazaki, N | 1 |
Anderson, H; Bishop, W; Lee, CW; Murray, N; Rao, SC | 1 |
Dickgreber, NJ; Fink, TH; Hossain, AM; Latz, JE; Musib, LC; Thomas, M | 1 |
Bergot, E; Lechapt, E; Zalcman, G | 1 |
Bodis, S; Günther, D; Jung, FJ; Lardinois, D; Latkoczy, C; Opitz, I; Rentsch, K; Rousson, V; Stahel, R; Varga, Z; Vuong, V; Weder, W | 1 |
Hughes, S; O'Brien, M; Popat, S; Wilkins, A | 1 |
Bogliolo, G; Bottino, GB; Esposito, M; Lerza, R; Pannacciulli, I; Vannozzi, M | 1 |
Bernareggi, A; Castoldi, D; Cimino, G; Colombi, L; Fracasso, ME; Leone, R; Monzani, V; Soresi, E; Tedeschi, M; Usari, T | 1 |
Bogliolo, GV; Bottino, GB; Esposito, M; Fulco, RA; Lerza, R; Mencoboni, MP; Merlo, F; Pannacciulli, IM; Vannozzi, M | 1 |
4 trial(s) available for platinum and Neoplasms, Pleural
Article | Year |
---|---|
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Platinum; Pleural Neoplasms | 2022 |
Phase 2 study of sorafenib in malignant mesothelioma previously treated with platinum-containing chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Male; Mesothelioma; Middle Aged; Neoplasm Staging; Niacinamide; Pemetrexed; Phenylurea Compounds; Platinum; Pleural Neoplasms; Prognosis; Protein Kinase Inhibitors; Salvage Therapy; Sorafenib; Survival Rate | 2013 |
Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dietary Supplements; Drug Administration Schedule; Female; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Mesothelioma; Middle Aged; Pemetrexed; Platinum; Pleural Neoplasms; Vitamins | 2009 |
Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Interactions; Drug Therapy, Combination; Etoposide; Glutathione; Half-Life; Humans; Lung Neoplasms; Mesothelioma; Platinum; Pleural Neoplasms; Time Factors | 1992 |
19 other study(ies) available for platinum and Neoplasms, Pleural
Article | Year |
---|---|
Treatment patterns and outcomes in older patients with advanced malignant pleural mesothelioma: Analyses of Surveillance, Epidemiology, and End Results-Medicare data.
Topics: Aged; Female; Humans; Male; Medicare; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Platinum; Pleural Neoplasms; Retrospective Studies; United States | 2022 |
[Analysis of the Efficacy of Pemetrexed Maintenance Therapy in Patients with
Malignant Pleural Mesothelioma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Neutropenia; Pemetrexed; Platinum; Pleural Neoplasms | 2022 |
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Australia; Humans; Immunohistochemistry; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Platinum; Pleural Neoplasms; Tumor Suppressor Proteins; Ubiquitin Thiolesterase | 2022 |
What's Current and What's New in Mesothelioma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Humans; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Pemetrexed; Platinum; Pleural Neoplasms | 2022 |
Elevated Circulating Activin A Levels in Patients With Malignant Pleural Mesothelioma Are Related to Cancer Cachexia and Reduced Response to Platinum-based Chemotherapy.
Topics: Activins; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cachexia; Carcinoma, Non-Small-Cell Lung; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Prognosis; Prospective Studies; Retrospective Studies; ROC Curve | 2020 |
Characteristics and long-term outcomes of advanced pleural mesothelioma in Latin America (MeSO-CLICaP).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Latin America; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pemetrexed; Platinum; Pleural Neoplasms; Progression-Free Survival; Thoracic Surgical Procedures | 2019 |
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; DNA Repair; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Survival Analysis; Tumor Suppressor Proteins; Ubiquitin Thiolesterase; Young Adult | 2019 |
Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: a retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Glutamates; Guanine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Staging; Palliative Care; Pemetrexed; Platinum; Pleural Neoplasms; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate | 2013 |
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Mesothelioma; Platinum; Pleural Neoplasms | 2013 |
Serum albumin as a significant prognostic factor in patients with malignant pleural mesothelioma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Pharmacological; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Platinum; Pleural Neoplasms; Prognosis; Proportional Hazards Models; Serum Albumin | 2014 |
Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Glutamates; Guanine; Humans; Male; Mesothelioma; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutagenesis, Insertional; Pemetrexed; Pharmacogenetics; Platinum; Pleural Neoplasms; Polymorphism, Genetic; Prognosis; Retrospective Studies; Survival Analysis; Tandem Repeat Sequences; Thymidylate Synthase; Treatment Outcome | 2014 |
Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Cell Adhesion Molecules; Cell Line, Tumor; Chemotherapy, Adjuvant; Cohort Studies; Deoxycytidine; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Gemcitabine; Humans; Induction Chemotherapy; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Nestin; Pemetrexed; Platinum; Pleural Neoplasms; Pneumonectomy; Prognosis; Sarcoma; Stem Cell Factor | 2015 |
Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.
Topics: Adult; Aged; Cisplatin; Female; Humans; Hyperthermia, Induced; Infusions, Intralesional; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Perfusion; Platinum; Pleural Cavity; Pleural Effusion, Malignant; Pleural Neoplasms; Prospective Studies; Thoracic Surgery, Video-Assisted | 2017 |
Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; British Columbia; Cisplatin; Clinical Trials, Phase II as Topic; Cohort Studies; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Platinum; Pleural Neoplasms; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome | 2009 |
Pemetrexed re-challenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?
Topics: Antineoplastic Agents; Glutamates; Guanine; Humans; Mesothelioma; Pemetrexed; Platinum; Pleural Neoplasms | 2011 |
Intrapleural topical application of cisplatin with the surgical carrier Vivostat increases the local drug concentration in an immune-competent rat model with malignant pleuromesothelioma.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Cisplatin; Drug Carriers; Fibrin Tissue Adhesive; Immunocompetence; Mesothelioma; Platinum; Pleura; Pleural Neoplasms; Rats; Rats, Inbred F344 | 2006 |
Malignant pleural mesothelioma: two cases in first degree relatives.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asbestos; Family; Humans; Male; Mesothelioma; Middle Aged; Platinum; Pleural Neoplasms; Tomography, X-Ray Computed | 2007 |
High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.
Topics: Absorption; Cisplatin; Drug Administration Schedule; Drug Tolerance; Feasibility Studies; Humans; Injections; Male; Mesothelioma; Middle Aged; Platinum; Pleura; Pleural Effusion, Malignant; Pleural Neoplasms; Remission Induction | 1994 |
Regional pharmacokinetic selectivity of intrapleural cisplatin.
Topics: Aged; Cisplatin; Female; Humans; Male; Mesothelioma; Platinum; Pleura; Pleural Neoplasms | 1991 |